Riskpilot
← Back to search
Sign in
Get full access
Slutplattan HERCO 123320 AB
AB
Dissolved
Org 5590304787
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2015
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Slutplattan HERCO 123320 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2025
SEK 0
EBITDA margin
—
-573% vs 2024
Equity ratio
89.8%
Financial strength
Net profit 2025
SEK -22K
-324% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 0
—
EBITDA
SEK -23K
-573%
Net profit
SEK -22K
-324%
Total assets
SEK 85K
-25%
Equity
SEK 76K
-22%
Employees
0
—
Company information
Legal name
Slutplattan HERCO 123320 AB
Org number
5590304787
Legal form
Aktiebolag
NACE code
4646 ·
Wholesale of pharmaceutical and medical goods
Founded
14 oktober 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Göteborg
All Sweden companies
Frequently asked questions
What is the Org number of Slutplattan HERCO 123320 AB?
Slutplattan HERCO 123320 AB is registered with Bolagsverket / SCB under Org 5590304787.
Who is the CEO of Slutplattan HERCO 123320 AB?
Anna Carina Christiansson is Audit of Slutplattan HERCO 123320 AB, in role since 2026.
Who is the chairman of Slutplattan HERCO 123320 AB?
Bo Torsten Patrik Nilsson chairs the board of Slutplattan HERCO 123320 AB, in role since 2026.
Riskpilot